Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|January 16, 1999
Definition of an unexpected ligand recognition motif for alphav beta6 integrinS Kraft, B Diefenbach, R Mehta, et al.
Journal of Medicinal Chemistry|September 18, 1992
Renin inhibitors containing new P1-P1' dipeptide mimetics with heterocycles in P1'P Raddatz, A Jonczyk, K O Minck, et al.
Journal of Colloid and Interface Science|March 6, 2003
Fusion of small unilamellar vesicles onto laterally mixed self-assembled monolayers of thiolipopeptidesT Baumgart, M Kreiter, H Lauer, et al.
International Journal of Cancer|August 5, 2000
In vivo therapy of malignant melanoma by means of antagonists of alphav integrinsF Mitjans, T Meyer, C Fittschen, et al.
The Journal of Clinical Investigation|January 12, 1999
Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonistC M Storgard, D G Stupack, A Jonczyk, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 14, 2001
RGD peptides and monoclonal antibodies, antagonists of alpha(v)-integrin, enter the cells by independent endocytic pathwaysS Castel, R Pagan, F Mitjans, et al.
Journal of Medicinal Chemistry|August 17, 1999
N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonistsM A Dechantsreiter, E Planker, B Mathä, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 17, 1999
Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastasesH N Lode, T Moehler, R Xiang, et al.
Pageof 3